-- Biotest Has 300 Million Euros for Acquisitions, Boersen Reports
-- B y   C o r n e l i u s   R a h n
-- 2012-06-15T18:03:24Z
-- http://www.bloomberg.com/news/2012-06-15/biotest-has-300-million-euros-for-acquisitions-boersen-reports.html
Biotest AG (BIO)  may spend as much as 300
million euros ($379 million) on acquisitions, Boersen-Zeitung
 reported , citing Chief Financial Officer Michael Ramroth.  Targets may include makers of clotting agents, the
newspaper cited the CFO as saying.  To contact the reporter on this story:
Cornelius Rahn in Frankfurt at 
 crahn2@bloomberg.net   To contact the editor responsible for this story:
Kenneth Wong at 
 kwong11@bloomberg.net  